Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2203992044
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blomley, M. J. K.
Right arrow Articles by Basilico, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blomley, M. J. K.
Right arrow Articles by Basilico, R.
(Radiology. 2001;220:661-667.)
© RSNA, 2001


Ultrasonography

Do Different Types of Liver Lesions Differ in Their Uptake of the Microbubble Contrast Agent SH U 508A in the Late Liver Phase? Early Experience1

Martin J. K. Blomley, MD, FRCR, Paul S. Sidhu, MB, FRCR, David O. Cosgrove, MB, FRCR, Thomas Albrecht, MD, FRCR, Christopher J. Harvey, MB, FRCR, Rolf A. Heckemann, MD, Jenny Butler-Barnes, RGN, Robert J. Eckersley, PhD and Raffaella Basilico, MD

1 From the Dept of Imaging, Hammersmith Hospital, Imperial College School of Medicine, 150 du Cane Rd, London W12 0HS, England (M.J.K.B., D.O.C., C.J.H., R.A.H., J.B.B., R.J.E.); Dept of Radiology, Kings College Hospital, London, England (P.S.S.); Dept of Radiology, Klinikum Benjamin Franklin, Berlin, Germany (T.A.); and Dept of Radiology, Univ of Chieti, Italy (R.B.). From the 1999 RSNA scientific assembly. Received Nov 23, 1999; revision requested Jan 5, 2000; final revision received Mar 6, 2001; accepted Apr 6. M.J.K.B. and C.J.H. supported by the Medical Research Council of the United Kingdom. Supported by Schering, Berlin, Germany, and Acuson, Stockley Park, England. Address correspondence to M.J.K.B. (e-mail: m.blomley@ic.ac.uk).

PURPOSE: To compare the uptake of SH U 508A in different types of liver lesions by using stimulated acoustic emission.

MATERIALS AND METHODS: Thirty-seven patients with characterized lesions (metastasis, n = 17; hepatocellular carcinoma, n = 4; hemangioma, n = 9; focal nodular hyperplasia, n = 7) received 2.5 g SH U 508A. After 5 minutes, stimulated acoustic emission was elicited by using a previously described method. Liver and/or lesional differences were assessed with videodensitometry (objective conspicuity score), and two observers assessed each lesion by using a six-point scale (subjective conspicuity score).

RESULTS: Metastases and hepatocellular carcinoma had low stimulated acoustic emission; median objective conspicuity scores were 70% and 68% (all scores were >=43%), respectively, and subjective conspicuity scores were 2 or higher for both observers. Hemangiomas had reduced stimulated acoustic emission, with more variability; the median objective conspicuity score was 41% (range, 9%–72%), and the median subjective conspicuity scores were 2 (range, 1–4) and 3.5 (range, 1–5) for observers 1 and 2, respectively. Focal nodular hyperplasia had stimulated acoustic emission comparable to that of the liver in all cases; the median objective conspicuity score was -4.7% (all scores were <6%), and the subjective conspicuity score was 1 or lower for both observers. This finding completely separated focal nodular hyperplasia and malignancies. Significant differences were seen between focal nodular hyperplasia and all other lesion types (P < .05).

CONCLUSION: Strong late-phase lesional uptake of SH U 508A is characteristic of focal nodular hyperplasia, is seen in some hemangiomas, and was not observed in malignancies.

Index terms: Liver neoplasms, diagnosis, 761.3198, 761.3194, 761.323, 761.33 • Liver neoplasms, US, 761.1296, 761.12981, 761.12983, 761.12988 • Ultrasound (US), contrast media, 761.12988




This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
E. Quaia, A. Palumbo, S. Rossi, F. Degobbis, S. Cernic, G. Tona, and M. Cova
Comparison of visual and quantitative analysis for characterization of insonated liver tumors after microbubble contrast injection.
Am. J. Roentgenol., June 1, 2006; 186(6): 1560 - 1570.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
V R Stewart and P S Sidhu
New directions in ultrasound: microbubble contrast.
Br. J. Radiol., March 1, 2006; 79(939): 188 - 194.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
C. Nicolau, R. Vilana, V. Catala, L. Bianchi, R. Gilabert, A. Garcia, and C. Bru
Importance of Evaluating All Vascular Phases on Contrast-Enhanced Sonography in the Differentiation of Benign from Malignant Focal Liver Lesions
Am. J. Roentgenol., January 1, 2006; 186(1): 158 - 167.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. Takeshima, T. Kumada, H. Toyoda, S. Kiriyama, M. Tanikawa, H. Ichikawa, T. Kawachi, and S. Ogawa
Comparison of IV Contrast-Enhanced Sonography and Histopathology of Pancreatic Cancer
Am. J. Roentgenol., November 1, 2005; 185(5): 1193 - 1200.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
H. Celik, H. Ozdemir, C. Yucel, S. Gultekin, S. O. Oktar, and M. Arac
Characterization of Hyperechoic Focal Liver Lesions: Quantitative Evaluation With Pulse Inversion Harmonic Imaging in the Late Phase of Levovist
J. Ultrasound Med., January 1, 2005; 24(1): 39 - 47.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
A. von Herbay, C. Vogt, R. Willers, and D. Haussinger
Real-time Imaging With the Sonographic Contrast Agent SonoVue: Differentiation Between Benign and Malignant Hepatic Lesions
J. Ultrasound Med., December 1, 2004; 23(12): 1557 - 1568.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. H. Bryant, M. J. Blomley, T. Albrecht, P. S. Sidhu, E. L. S. Leen, R. Basilico, J. M. Pilcher, L. H. Bushby, C. W. Hoffmann, C. J. Harvey, et al.
Improved Characterization of Liver Lesions with Liver-Phase Uptake of Liver-specific Microbubbles: Prospective Multicenter Study
Radiology, September 1, 2004; 232(3): 799 - 809.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
E. Quaia, F. Calliada, M. Bertolotto, S. Rossi, L. Garioni, L. Rosa, and R. Pozzi-Mucelli
Characterization of Focal Liver Lesions with Contrast-specific US Modes and a Sulfur Hexafluoride-filled Microbubble Contrast Agent: Diagnostic Performance and Confidence
Radiology, August 1, 2004; 232(2): 420 - 430.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
V. Migaleddu, G. Virgilio, D. Turilli, M. Conti, G. Campisi, N. Canu, D. Sirigu, and I. Vincentelli
Characterization of Focal Liver Lesions in Real Time Using Harmonic Imaging with High Mechanical Index and Contrast Agent Levovist
Am. J. Roentgenol., June 1, 2004; 182(6): 1505 - 1512.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
C F Dietrich, A Ignee, J Trojan, C Fellbaum, and G Schuessler
Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A
Gut, March 1, 2004; 53(3): 401 - 405.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
A. von Herbay, C. Vogt, and D. Haussinger
Differentiation Between Benign and Malignant Hepatic Lesions: Utility of Color Stimulated Acoustic Emission With the Microbubble Contrast Agent Levovist
J. Ultrasound Med., February 1, 2004; 23(2): 207 - 215.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
H-D Liang and M J K Blomley
The role of ultrasound in molecular imaging
Br. J. Radiol., December 1, 2003; 76(suppl_2): S140 - S150.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
J. H. Youk, C. S. Kim, and J. M. Lee
Contrast-Enhanced Agent Detection Imaging: Value in the Characterization of Focal Hepatic Lesions
J. Ultrasound Med., September 1, 2003; 22(9): 897 - 910.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
J. H. Youk, J. M. Lee, and C. S. Kim
Therapeutic Response Evaluation of Malignant Hepatic Masses Treated by Interventional Procedures With Contrast-Enhanced Agent Detection Imaging
J. Ultrasound Med., September 1, 2003; 22(9): 911 - 920.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. Albrecht, M. J. K. Blomley, P. N. Burns, S. Wilson, C. J. Harvey, E. Leen, M. Claudon, F. Calliada, J.-M. Correas, M. LaFortune, et al.
Improved Detection of Hepatic Metastases with Pulse-Inversion US during the Liver-specific Phase of SHU 508A: Multicenter Study
Radiology, May 1, 2003; 227(2): 361 - 370.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
A K P Lim, N Patel, W M W Gedroyc, M J K Blomley, G Hamilton, and S D Taylor-Robinson
Hepatocellular adenoma: diagnostic difficulties and novel imaging techniques
Br. J. Radiol., August 1, 2002; 75(896): 695 - 699.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2001 by the Radiological Society of North America.